These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 31009195)
1. Fluorescence Chemicals To Detect Insoluble and Soluble Amyloid-β Aggregates. Lee D; Kim SM; Kim HY; Kim Y ACS Chem Neurosci; 2019 Jun; 10(6):2647-2657. PubMed ID: 31009195 [TBL] [Abstract][Full Text] [Related]
2. Engineering of donor-acceptor-donor curcumin analogues as near-infrared fluorescent probes for Fang D; Wen X; Wang Y; Sun Y; An R; Zhou Y; Ye D; Liu H Theranostics; 2022; 12(7):3178-3195. PubMed ID: 35547754 [TBL] [Abstract][Full Text] [Related]
3. Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer's disease. Jung SJ; Park SH; Lee EJ; Park JH; Kong YB; Rho JK; Hur MG; Yang SD; Park YD Arch Pharm Res; 2015 Nov; 38(11):1992-8. PubMed ID: 26012373 [TBL] [Abstract][Full Text] [Related]
4. Fluorescent 2-styrylpyridazin-3(2H)-one derivatives as probes targeting amyloid-beta plaques in Alzheimer's disease. Park YD; Park JH; Hur MG; Kim SW; Min JJ; Park SH; Yoo YJ; Yoon YJ; Yang SD Bioorg Med Chem Lett; 2012 Jun; 22(12):4106-10. PubMed ID: 22578456 [TBL] [Abstract][Full Text] [Related]
5. Advances in fluorescent probes for detection and imaging of amyloid-β peptides in Alzheimer's disease. Zhang Y; Ding C; Li C; Wang X Adv Clin Chem; 2021; 103():135-190. PubMed ID: 34229849 [TBL] [Abstract][Full Text] [Related]
6. The interaction of insoluble Amyloid-β with soluble Amyloid-β dimers decreases Amyloid-β plaque numbers. van Gerresheim EF; Herring A; Gremer L; Müller-Schiffmann A; Keyvani K; Korth C Neuropathol Appl Neurobiol; 2021 Aug; 47(5):603-610. PubMed ID: 33338256 [TBL] [Abstract][Full Text] [Related]
7. Discovery of boronic acid-based fluorescent probes targeting amyloid-beta plaques in Alzheimer's disease. Jung SJ; Lee JY; Kim TH; Lee DE; Jeon J; Yang SD; Hur MG; Min JJ; Park YD Bioorg Med Chem Lett; 2016 Apr; 26(7):1784-8. PubMed ID: 26927427 [TBL] [Abstract][Full Text] [Related]
8. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains. Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334 [TBL] [Abstract][Full Text] [Related]
9. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice. Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082 [TBL] [Abstract][Full Text] [Related]
11. Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin. Maiti P; Plemmons A; Bowers Z; Weaver C; Dunbar G J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736502 [TBL] [Abstract][Full Text] [Related]
12. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"]. Tamaoka A Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113 [TBL] [Abstract][Full Text] [Related]
13. IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques. Kung MP; Hou C; Zhuang ZP; Zhang B; Skovronsky D; Trojanowski JQ; Lee VM; Kung HF Brain Res; 2002 Nov; 956(2):202-10. PubMed ID: 12445687 [TBL] [Abstract][Full Text] [Related]
14. Versatile fluorescent probes for near-infrared imaging of amyloid-β species in Alzheimer's disease mouse model. Peng C; Wang X; Li Y; Li HW; Wong MS J Mater Chem B; 2019 Mar; 7(12):1986-1995. PubMed ID: 32254802 [TBL] [Abstract][Full Text] [Related]
15. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842 [TBL] [Abstract][Full Text] [Related]
16. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain. Fang XT; Hultqvist G; Meier SR; Antoni G; Sehlin D; Syvänen S Neuroimage; 2019 Jan; 184():881-888. PubMed ID: 30300753 [TBL] [Abstract][Full Text] [Related]
17. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478 [TBL] [Abstract][Full Text] [Related]
18. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234 [TBL] [Abstract][Full Text] [Related]
19. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. Bloom GS JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463 [TBL] [Abstract][Full Text] [Related]
20. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease. Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]